FDA Approves Four 2009 H1N1 Vaccines

The U.S. Food and Drug Administration announced that it has approved four vaccines against the 2009 H1N1 influenza virus. The vaccines will be distributed nationally after the initial lots become available, which is expected within the next four weeks.

“Today's approval is good news for our nation's response to the 2009 H1N1 influenza virus,” Commissioner of Food and Drugs Margaret A. Hamburg, M.D., said this week. “This vaccine will help protect individuals from serious illness and death from influenza.”

The vaccines are made by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and sanofi pasteur Inc. All four firms manufacture the H1N1 vaccines using the same processes, which have a long record of producing safe seasonal influenza vaccines, FDA said.

”The H1N1 vaccines approved today undergo the same rigorous FDA manufacturing oversight, product quality testing and lot release procedures that apply to seasonal influenza vaccines,” said Jesse Goodman, M.D., FDA acting chief scientist, on Tuesday.

Based on preliminary data from adults participating in multiple clinical studies, the 2009 H1N1 vaccines induce a robust immune response in most healthy adults eight to 10 days after a single dose, as occurs with the seasonal influenza vaccine, FDA said, adding that clinical studies underway will provide additional information about the optimal dose in children. The recommendations for dosing will be updated if indicated by findings from those studies. The findings are expected in the near future.

As with the seasonal influenza vaccines, the 2009 H1N1 vaccines are being produced in formulations that contain thimerosal, a mercury-containing preservative, and in formulations that do not contain thimerosal. FDA noted that people with severe or life-threatening allergies to chicken eggs, or to any other substance in the vaccine, should not be vaccinated. The agency added that in the ongoing clinical studies, the vaccines have been well tolerated. Potential side effects of the H1N1 vaccines are expected to be similar to those of seasonal flu vaccines.

For the injected vaccine, the most common side effect is soreness at the injection site. Other side effects, according to FDA, may include mild fever, body aches, and fatigue for a few days after the inoculation. For the nasal spray vaccine, the most common side effects include runny nose or nasal congestion for all ages, sore throats in adults, and--in children 2 to 6 years old--fever.

FDA notes that, as with any medical product, unexpected or rare serious adverse events may occur. The agency said it is working closely with governmental and nongovernmental organizations to enhance the capacity for adverse event monitoring, information sharing, and analysis during and after the 2009 H1N1 vaccination program. In the U.S. Department of Health and Human Services, these agencies include the Centers for Disease Control and Prevention.

Vaccines against three seasonal virus strains are already available and should be used, FDA said. However, they do not protect against the 2009 H1N1 virus. These latest four vaccines are designed to do that.

Download Center

  • Hand Safety Program

    Hand injuries are the #1 preventable industrial accident worldwide. In REThink Hand Safety, the most comprehensive book on hand safety, you'll learn how top companies have reduced hand injuries by up to 90% and what the most successful hand safety programs have in common. Get your free copy today.

  • Free 1-on-1 Consultations

    Get a free meeting with a Superior Glove hand safety expert and learn how to have less hand injuries, lower PPE costs, and increase worker productivity. 1-on-1 consultations provide you with personalized advice and recommendations for your specific needs and concerns.

  • Glove 101 Guide

    In this comprehensive guide, we've compiled all the key information you need to know about safety gloves to help you make informed decisions when choosing gloves for your workers. Whether you're new to the world of safety gloves or an experienced pro, this guide has something for everyone.

  • Sample Program

    Find the right safety gloves for your team and try before you buy—in just 3 easy steps! Simply add the products to your sample box, complete the request form, and wait for your samples to arrive at no cost to you.

  • Cut Protection Product Guide

    Find the right safety gloves for your workers to protect them from cut hazards. This guide offers a wide selection of gloves, including ultra-thin gloves with the industry’s maximum cut resistance for unbeatable dexterity and touch sensitivity.

  • Superior Glove

Featured Whitepaper

OH&S Digital Edition

  • OHS Magazine Digital Edition - February March 2023

    February March 2023

    Featuring:

    • IH: GAS DETECTION
      Does Real-Time Data Enhance Gas Detection Programs?
    • PPE: HEARING PROTECTION
      Hearing Protection: The Dangers of Non-Compliance
    • PPE: PROTECTIVE APPAREL
      Personal Protective Equipment: The Pains of Staying Pain-Free
    • CONSTRUCTION SAFETY
      Reframing Eyewear: Meeting Workforce Needs with Technology and Advancements
    View This Issue